The term “Genetron” is derived from Darwin's "pangenesis theory", the
original definition of human genetic material—genes.
Health (Nasdaq:GTH) is a leading precision oncology platform company in
China that specializes in cancer molecular profiling and harnesses advanced
technologies in molecular biology and data science to transform cancer
treatment. The Company has developed a comprehensive oncology portfolio that
covers the entire spectrum of cancer management, addressing needs and
challenges from early screening, diagnosis and treatment recommendations,
continuous disease monitoring and care, as wells as biopharma development
services. Genetron Health offers customized services and products. The
ultimate goal is to defeat cancer.
DIVERSIFIED SOLUTIONS COVERING THE
FULL-CYCLE OF CANCER MANAGEMENT
DIAGNOSTICS & MONITORING
BIOPHARMA DEVELOPMENT SERVICES
Genetron Health Brand Values
Our team of scientists has extensive experience in cancer genomics research, clinical and translational research. Our scientists have published more than one hundred papers in leading international academic journals. Our research fields include cancers of the lung, digestive tract, thyroid and the central nervous system. Genetron Health has established long-term partnerships with Duke University and Johns Hopkins University. Genetron Health’s innovative One-Step Seq Method and Mutation Capsule have proven to bring significant benefits to the clinical management of cancer.
Health's product and service solutions span the fields of early cancer
screening, diagnosis and monitoring, biopharma services. Covering top ten
major cancer types in China. Our products are capable of detecting multiple
tissue and liquid sample forms. The two forms of "LDT testing service + IVD
instrument reagent" focused on clinical appeals, have reliable service and
product quality assurance. We have also been involved in writing a number of
industry standards, and we are committed to providing solutions for healthy
and high-risk groups, patients, doctors, and pharmaceutical companies.
Genetron Health takes advantage of global R&D resources. We focus on the
Chinese market, but partner with global companies such as Illumina, Thermo
Fisher, BGI, Roche, AstraZeneca, InnoCare, and CStone Pharmaceuticals. With
our own global resources, we are committed to providing more people with
products and services that cover the full cancer cycle.
Adhering to the mission of “Defeat Cancer and Protect Life”, Genetron Health
is committed to becoming an excellent corporate citizen and protecting
public health. We do this by focusing on users and providing users with
products and services throughout the full cancer cycle. We do this by
focusing on our employees, paying attention to their growth, by emphasizing
equality and inclusiveness, by providing career opportunities through R & D
and management, and by helping employees to achieve their dreams and ideals.
We do this by focusing on the public and promoting the social awareness of
the significance of precision medicine to health through public welfare such
as health science popularization and community service.